Nephropathy News and Research

RSS
Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete any waste products and to regulate the water and acid-base balance of the body – therefore loss of kidney function is a potentially fatal condition.
Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

Study reports safety, efficacy of targeted treatment for IgA nephropathy

Study reports safety, efficacy of targeted treatment for IgA nephropathy

New enzyme may help curb chronic kidney disease

New enzyme may help curb chronic kidney disease

New review supports stricter control of HbA1C levels among children with type 1 diabetes

New review supports stricter control of HbA1C levels among children with type 1 diabetes

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

High-impact clinical trial results could improve kidney-related medical care

High-impact clinical trial results could improve kidney-related medical care

Phase 2 clinical trial to examine the effects of razuprotafib on COVID-19 patients

Phase 2 clinical trial to examine the effects of razuprotafib on COVID-19 patients

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

Phase 3 study to test efficacy of new treatment for pediatric acute-onset neuropsychiatric syndrome

SGLT2 inhibitors can slow CKD progression

SGLT2 inhibitors can slow CKD progression

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Researchers identify underlying mechanism for metabolic memory and diabetic complications

Researchers identify underlying mechanism for metabolic memory and diabetic complications

Study results do not show benefit of proteomic analysis for detecting diabetic nephropathy

Study results do not show benefit of proteomic analysis for detecting diabetic nephropathy

Repurposed drug for acute lung injury in COVID-19

Repurposed drug for acute lung injury in COVID-19

Study explores time trends in pregnancy-related outcomes among women with type 1 diabetes

Study explores time trends in pregnancy-related outcomes among women with type 1 diabetes

Octapharma extends support for COVID-19 study following promising preliminary data

Octapharma extends support for COVID-19 study following promising preliminary data

FDA approves IND application by Octapharma USA for severe COVID-19 patients

FDA approves IND application by Octapharma USA for severe COVID-19 patients

Study suggests ROBO2 pathway as therapeutic target for kidney diseases

Study suggests ROBO2 pathway as therapeutic target for kidney diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.